Title | Fig. 8. The effectiveness of vedolizumab in UC after 12 months of therapy, depending on the response to hormone therapy. |
Submission | Vedolizumab in patients with inflammatory bowel diseases of in real clinical practice |
Type | — |
Date | 2020-04-26 |
Supplementary File
File Name | 33909-57423-1-SP.JPG |
Original file name | 11-8.JPG |
File Size | 46KB |
Date uploaded | 26.04.2020 23:48 |